Proteasomal down-regulation of the proapoptotic mst2 pathway contributes to braf inhibitor resistance in melanoma

HIGHLIGHTS

  • who: David Romano and collaborators from the Systems Biology Ireland, School of Medicine, University College Dublin, Dublin, Ireland Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland Massachusetts General Hospital, Boston, MA, USA Department of Biology/Whitney Laboratory for Marine Bioscience, University of Florida, Gainesville, FL, USA have published the article: Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma, in the Journal: (JOURNAL)
  • what: The authors show that mutant BRAFV600E binds and inhibits MST2 preventing the activation of MST2-dependent apoptosis. In BRAFi resistant melanoma . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?